1. Pink Sheet

Brexit & Covid Impact On UK Cancer Trials ‘Dissipating’

 
• By Eliza Slawther

Brexit has been cited as a cause of the UK’s 2020 decline in clinical trials, but research suggests that other global trends including the pandemic also had a large impact. Meanwhile, the MHRA’s efforts to incentivize sponsors could boost trial figures “substantially,” an expert says.

Clinical Trial
• Source: Shutterstock

While Brexit undoubtedly had an impact on the UK’s clinical trial ecosystem, research published in the BMJ Oncology on 14 August found that this was not the only driving force behind a drop in trials in the 2019-2021 period.

Between 2019 and 2020 there was a decrease in the initiation of oncology trials in the UK

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D